Furthermore, loss of MSI-1 expression resulted in decreased proliferation and treatment resistance of breast cancer cells and increased apoptosis by competitively binding to tachykinin (TAC1) mRNA with miR-130a and miR-206 to stabilize and increase its translation (44). Here, MSI1 is linked to breast cancer.